Basic biochemical investigations as rationale for the design of original antimalarial drugs. An example of phospholipid metabolism

by Henri J. Vial, Marie L. Angelin, Nourredine Elabbadi, Michele Calas, Gerard Cordinas, Louis Giral
Published 1992-01-01

Rodent and nonrodent malaria parasites differ in their phospholipid metabolic pathways[S]

by Sandrine Déchamps, Marjorie Maynadier, Sharon Wein, Laila Gannoun-Zaki, Eric Maréchal, Henri J. Vial
Published 2010-01-01

Infected erythrocyte choline carrier inhibitors: exploring some potentialities inside Plasmodium phospholipid metabolism for eventual resistance acquisition

by Henri J. Vial, Marie L. Ancelin, Noureddine Elabbadi, Hélène Orcel, Hye-Jeong Yeo, Catherine Gumila
Published 1994-01-01

A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and c...

by Diana Marcela Penarete-Vargas, Anaïs Boisson, Serge Urbach, Hervé Chantelauze, Suzanne Peyrottes, Laurent Fraisse, Henri J Vial
Published 2014-01-01

Contribution of the precursors and interplay of the pathways in the phospholipid metabolism of the malaria parasite

by Sharon Wein, Salma Ghezal, Corinne Buré, Marjorie Maynadier, Christian Périgaud, Henri J. Vial, Isabelle Lefebvre-Tournier, Kai Wengelnik, Rachel Cerdan
Published 2018-08-01

Present development concerning antimalarial activity of phospholipid metabolism inhibitors with special reference to in vivo activity

by Marie L. Ancelin, Henri J. Vial, Michele Calas, Louis Giral, Gilles Piquet, Eric Rubi, Alan Thomas, Wallace Peters, Christian Slomianny, Socrates Herrera, F. Louis, Vincent Mouanda
Published 1994-01-01

Phosphatidylinositol 3-monophosphate is involved in toxoplasma apicoplast biogenesis.

by Lina Tawk, Jean-François Dubremetz, Philippe Montcourrier, Gaëtan Chicanne, Fabrice Merezegue, Véronique Richard, Bernard Payrastre, Markus Meissner, Henri J Vial, Christian Roy, Kai Wengelnik, Maryse Lebrun
Published 2011-02-01

SC83288 is a clinical development candidate for the treatment of severe malaria

by Stefano Pegoraro, Maëlle Duffey, Thomas D Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K Fehler, Leonardo Lucantoni, Vicky M Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J Vial, Stefan Strobl, Cecilia P Sanchez, Michael Lanzer
Published 2017-01-01

Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

by Stefano Pegoraro, Maëlle Duffey, Thomas D. Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K. Fehler, Leonardo Lucantoni, Vicky M. Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J. Vial, Stefan Strobl, Cecilia P. Sanchez, Michael Lanzer
Published 2017-04-01